Table 1.
Antibiotics that impact biofilm formation that are mentioned in this paper.
| Compound Source | Compound | Bacterial species effected | Reference |
|---|---|---|---|
|
| |||
| Amphibian skin | Dermaseptin S4 derivative | Pseudomonas fluorescens | 67 |
|
| |||
| Bacteria | 2,4-diacetylphloroglucinol | Bacillus subtilis | 21 |
|
| |||
| Bacteria | Biosurfactants | Acinetobacter baumannii | 53 |
| Escherichia coli | |||
| Staphylococcus aureus | |||
|
| |||
| Bacteria | Biosurfactants putisolvins I and II | Pseudomonas spp. | 52 |
|
| |||
| Bacteria | Polymyxin B | Vibrio cholerae | 59 |
|
| |||
| Bacteria | Subtilosin | Gardnerella vaginalis | 65, 64 |
|
| |||
| Bacteria | Surfactin | B. subtilis | 18 |
| Nystatin | |||
|
| |||
| Bacteria | Tetracycline | Staphylococcus epidermidis | 55 |
|
| |||
| Bacteria | Thiocillin | B. subtilis | 20 |
| Various thiazolyl peptides | |||
|
| |||
| Bacteria | Tobramycin | E. coli | 41 |
| Pseudomonas aeruginosa | |||
|
| |||
| Bacteria/semisynthetic | Carbapenem | Klebsiella pneumoniae | 51 |
|
| |||
| Bacteria/synthetic | Ampicillin | Streptococcus intermedius | 63 |
| Ciprofloxacin | |||
| Tetracycline | |||
|
| |||
| Human | Defence peptide LL-37 | S. aureus | 57 |
| P. aeruginosa | |||
|
| |||
| Lichen | Usnic Acid | P. aeruginosa | 54 |
| S. aureus | |||
|
| |||
| Marine algae | Furanone | E. coli | 48, 62, 60 |
| P. aeruginosa | |||
| S. aureus | |||
| S. epidermidis | |||
|
| |||
| Semisynthetic | Ampicillin | S. aureus | 50 |
| Amoxicillin | |||
| Cloxacillin | |||
| Methicillin | |||
|
| |||
| Semisynthetic | Azithromycin | P. aeruginosa | 44–47 |
|
| |||
| Synthetic | Peptide 1037 | P. aeruginosa | 58 |
| Burkholderia cenocepacia | |||
| Listeria monocytogenes | |||